Durgical
EN
Open the app

Rh and red cell alloimmunisation: prevention and follow-up

  • Routine care

An Rh-negative mother can make antibodies that attack a later baby's blood. A timely injection of anti-D prevents it; once antibodies exist, it cannot.

Updated

What it is

Red cell alloimmunisation happens when a mother makes antibodies against an antigen on her fetus's red cells that she lacks, most often RhD. Fetal cells enter her circulation at birth, during bleeding, miscarriage, ectopic pregnancy, procedures or trauma. Her IgG antibodies cross the placenta in a later pregnancy and destroy fetal red cells: haemolytic disease of the fetus and newborn, from mild jaundice to severe anaemia, hydrops and death. Anti-D immunoglobulin given at the right times prevents RhD sensitisation. Other antibodies (anti-Kell, anti-c, anti-E) cannot be prevented and are followed the same way.

What it looks for

  • Blood group, RhD type and antibody screen for every pregnant woman at the first visit.
  • RhD-negative women without anti-D antibodies receive routine anti-D at about 28 weeks, as the national route sets.
  • Give anti-D within 72 hours after the birth of an RhD-positive baby, and after sensitising events: miscarriage, ectopic pregnancy, termination, bleeding, abdominal trauma, external cephalic version, amniocentesis or chorionic villus sampling.
  • The Kleihauer-Betke test (or flow cytometry) measures how much fetal blood entered the mother after birth or trauma, to see if more anti-D is needed.
  • Middle cerebral artery Doppler: a high peak systolic velocity means the fetal blood is thin, which signals fetal anaemia without a needle.

How it is done

  1. First visit: blood group, RhD and antibody screen for all; repeat the antibody screen in RhD-negative women as the route sets.
  2. RhD-negative and not sensitised: give anti-D at about 28 weeks and after any sensitising event.
  3. At birth: check the baby's blood group; if RhD-positive, give anti-D to the mother within 72 hours and size the bleed when it may be large.
  4. Antibodies found: identify them and measure the titre; check the father's antigen type or fetal RhD from maternal blood where available.
  5. Titre above the critical level (or anti-Kell at any level): refer to fetal medicine for serial middle cerebral artery Doppler.
  6. Signs of fetal anaemia: fetal blood sampling and intrauterine transfusion in a specialist centre; plan birth timing there.
  7. Newborn of a sensitised mother: blood group, direct antiglobulin test, haemoglobin and bilirubin; phototherapy or exchange transfusion as needed.

Three kinds of maternal antibody disease

FeatureAnti-D (Rh)Anti-KellABO incompatibility
WhoRhD-negative mother, RhD-positive fetusKell-negative mother, often sensitised by transfusionUsually group O mother, group A or B baby
First pregnancy affected?Rarely; needs earlier sensitisationYes, if sensitised beforeYes, can occur in the first
MechanismHaemolysis of fetal red cellsHaemolysis plus suppression of red cell productionMild haemolysis (IgG anti-A or anti-B)
SeverityMild to hydropsCan be severe even at low titreMild; jaundice in the newborn, rarely hydrops
PreventionAnti-D immunoglobulinNone; avoid unmatched transfusion in girls and womenNone needed

Common mistakes

  • Forgetting anti-D after a miscarriage, ectopic pregnancy or bleeding in an RhD-negative woman: these are sensitising events.
  • Giving anti-D to a woman who already has anti-D antibodies and believing it protects her: it does not, and her pregnancy needs specialist follow-up.
  • Missing the 72-hour window after birth because the baby's group was not checked.
  • Relying on titres for anti-Kell: Kell antibodies also suppress fetal red cell production, so anaemia can be severe at low titres.

Next step / When to refer

  • Make sure every RhD-negative woman has a written plan for anti-D at about 28 weeks, after events and after birth.
  • Refer to fetal medicine any woman with clinically significant red cell antibodies, a rising titre, a previous affected baby or anti-Kell.
  • Signs of severe fetal anaemia (high middle cerebral artery velocity, hydrops: skin oedema, ascites, effusions) need urgent referral for intrauterine transfusion.
  • Alert the neonatal team before the birth of a baby at risk of haemolytic disease.

Common traps

  • The first Rh-positive baby is in danger: the first exposure usually makes IgM that does not cross the placenta; the risk is in later pregnancies once IgG memory exists.
  • Anti-D helps a woman who already has antibodies: it only prevents sensitisation; once she has antibodies, the pregnancy needs monitoring, not prophylaxis.
  • Bilirubin is the danger before birth: the placenta clears fetal bilirubin, so in utero the danger is anaemia and hydrops; jaundice and kernicterus come after birth.
  • ABO incompatibility is as dangerous as Rh disease: anti-A and anti-B cause mostly mild newborn jaundice, because A and B antigens are weak on fetal red cells and found on many other tissues.

Test yourself

Think of the answer, then tap the question to see it.

Why is the first RhD-positive pregnancy of an RhD-negative woman rarely affected?

Sensitisation usually happens at the first birth and first produces IgM, which does not cross the placenta; IgG memory then attacks later RhD-positive fetuses.

An RhD-negative woman without antibodies has a miscarriage at 10 weeks. What should she receive and why?

Anti-D immunoglobulin, because a miscarriage can let fetal RhD-positive cells into her circulation and sensitise her for later pregnancies.

How is fetal anaemia detected without a needle?

By Doppler of the middle cerebral artery: anaemic, thinner blood flows faster, so a peak systolic velocity above the threshold for the gestational age suggests anaemia.

Why is anti-Kell alloimmunisation managed more aggressively than anti-D at the same titre?

Anti-Kell suppresses fetal red cell production as well as destroying cells, so severe anaemia can occur even at low titres.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of obstetrics and gynaecology

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: Rho(D) Immune Globulin (StatPearls Publishing (NCBI Bookshelf), 2023); Hemolytic Disease of the Fetus and Newborn (StatPearls Publishing (NCBI Bookshelf), 2025); Kleihauer-Betke Test (StatPearls Publishing (NCBI Bookshelf), 2026); Rh incompatibility (MedlinePlus (U.S. National Library of Medicine), 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.